Detalles de la búsqueda
1.
Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering.
PLoS Pathog;
16(2): e1008287, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32032366
2.
Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer.
Antimicrob Agents Chemother;
65(11): e0141821, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34460302
3.
Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model.
Antimicrob Agents Chemother;
64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32205344
4.
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Antimicrob Agents Chemother;
63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036687
5.
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
Antimicrob Agents Chemother;
63(3)2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559131
6.
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.
Antimicrob Agents Chemother;
63(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833432
7.
Mutations in Rv0678 Reduce Susceptibility of Mycobacterium tuberculosis to the DprE1 Inhibitor TBA-7371.
Antimicrob Agents Chemother;
67(3): e0005223, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36786606
8.
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
Antimicrob Agents Chemother;
62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038265
9.
Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
Antimicrob Agents Chemother;
62(7)2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735562
10.
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.
Proc Natl Acad Sci U S A;
112(3): 869-74, 2015 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25561537
11.
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.
J Antimicrob Chemother;
72(2): 455-461, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27798204
12.
Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.
Antimicrob Agents Chemother;
60(5): 2864-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26926638
13.
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
PLoS Med;
12(9): e1001880, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26418737
14.
Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
Antimicrob Agents Chemother;
59(4): 2129-35, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25624335
15.
Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.
Antimicrob Agents Chemother;
59(6): 3042-51, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25753644
16.
Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor.
Am J Respir Crit Care Med;
188(5): 600-7, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23805786
17.
Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.
Am J Respir Crit Care Med;
188(5): 608-12, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23822735
18.
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.
J Antimicrob Chemother;
68(3): 659-65, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129730
19.
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis.
ACS Infect Dis;
9(2): 221-238, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606559
20.
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
Am J Respir Crit Care Med;
183(9): 1254-61, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21330452